AVIR - Atea Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

AVIR is currently covered by 2 analysts with an average potential upside of $3.62 (31.42%) backed by displayed 6 price targets and 12 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.33% with an average time for these price targets to be met of 56 days.

Highest price target for AVIR is 9, Lowest price target is 8, average price target is 8.5.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 10-Aug-2023. First documented stock forecast 29-Jan-2021.

Best performing analysts who are covering AVIR - Atea Pharmaceuticals:

Matthew Harrison Eric Joseph

Currently, out of the existing stock ratings of AVIR - 1 which are a Hold (33.33%), 1 which are a Buy (33.33%), 1 which are a Sell (33.33%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

8

3 months 20 days ago

2/5 (40%)

$3.52 (37.47%)

60

Sell

7

$4.1 (141.38%)

14

1 years 3 months 15 days ago

4/6 (66.67%)

$3.72 (25.37%)

52

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AVIR (Atea Pharmaceuticals) average time for price targets to be met?

On average it took 56 days on average for the stock forecasts to be realized with a an average price target met ratio 53.33

Which analyst has the current highest performing score on AVIR (Atea Pharmaceuticals) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals)?

Matthew Harrison works at MORGAN STANLEY and has 6 price targets and 3 ratings on AVIR

Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals)?

Matthew Harrison with highest potential upside - $4.1

Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals)?

Eric Joseph with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart